In December 2020, we entered into a product manufacturing and supply agreement with STEMCELL Technologies, or STEMCELL, a biotechnology company that develops and supplies specialized cell culture med…
funds are secured for its execution. While our upstream and downstream processes are quite robust and efficient, we continuously invest in further yield improvement and scalability, in order to reduc…
Reciprocal relationship from JNJ graph: Reciprocal relationship from CLGN graph: funds are secured for its execution. While our upstream and downstream processes are quite robust and efficient, we co…
funds are secured for its execution. While our upstream and downstream processes are quite robust and efficient, we continuously invest in further yield improvement and scalability, in order to reduc…
Reciprocal relationship from JNJ graph: Reciprocal relationship from CLGN graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from CLGN graph: Reciprocal relationship from JNJ grap…
CollPlant Biotechnologies Ltd. Debt Obligations
Instrument
Description
Confidence
Evidence
CLGN-DEBT
Debt stack $2.8M
90%
Market cache reports total debt of $2.8M.
CLGN-DEBT-8679
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2017-12-31.
CLGN-DEBT-8678
Warrants outstanding: 72000
90%
xbrl warrant detail from xbrl 2025-06-02.
CollPlant Biotechnologies Ltd. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for CollPlant Biotechnologies Ltd..
CollPlant Biotechnologies Ltd. Ownership
Holder
Name
Confidence
Evidence
CLGN-OWNER-PARALLEL-ADVISORS-LLC
Parallel Advisors, LLC
90%
13F overlay lists Parallel Advisors, LLC as top holder; 1 tracked holders.